Logo image of TSE

TRINSEO PLC (TSE) Stock Fundamental Analysis

NYSE:TSE - IE0000QBK8U7 - Common Stock

2.38 USD
-0.07 (-2.86%)
Last: 8/28/2025, 3:00:44 PM
Fundamental Rating

1

Overall TSE gets a fundamental rating of 1 out of 10. We evaluated TSE against 84 industry peers in the Chemicals industry. TSE may be in some trouble as it scores bad on both profitability and health. TSE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year TSE has reported negative net income.
In the past year TSE has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: TSE reported negative net income in multiple years.
TSE had a positive operating cash flow in 4 of the past 5 years.
TSE Yearly Net Income VS EBIT VS OCF VS FCFTSE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

TSE has a worse Return On Assets (-14.81%) than 78.57% of its industry peers.
Industry RankSector Rank
ROA -14.81%
ROE N/A
ROIC N/A
ROA(3y)-15.93%
ROA(5y)-7.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TSE Yearly ROA, ROE, ROICTSE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

1.3 Margins

TSE's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 7.27%, TSE is not doing good in the industry: 86.90% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of TSE has declined.
TSE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.27%
OM growth 3Y-72.52%
OM growth 5Y-32.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.47%
GM growth 5Y-3.22%
TSE Yearly Profit, Operating, Gross MarginsTSE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

More info and screens

1

2. Health

2.1 Basic Checks

TSE does not have a ROIC to compare to the WACC, probably because it is not profitable.
TSE has more shares outstanding than it did 1 year ago.
TSE has less shares outstanding than it did 5 years ago.
TSE has a worse debt/assets ratio than last year.
TSE Yearly Shares OutstandingTSE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
TSE Yearly Total Debt VS Total AssetsTSE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 0.80, we must say that TSE is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.80, TSE is not doing good in the industry: 80.95% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.8
ROIC/WACCN/A
WACC7.04%
TSE Yearly LT Debt VS Equity VS FCFTSE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.42 indicates that TSE should not have too much problems paying its short term obligations.
TSE has a Current ratio of 1.42. This is in the lower half of the industry: TSE underperforms 76.19% of its industry peers.
A Quick Ratio of 0.89 indicates that TSE may have some problems paying its short term obligations.
TSE has a worse Quick ratio (0.89) than 72.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 0.89
TSE Yearly Current Assets VS Current LiabilitesTSE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

3

3. Growth

3.1 Past

TSE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.85%.
Looking at the last year, TSE shows a decrease in Revenue. The Revenue has decreased by -7.97% in the last year.
TSE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.81% yearly.
EPS 1Y (TTM)-4.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-45.21%
Revenue 1Y (TTM)-7.97%
Revenue growth 3Y-10.05%
Revenue growth 5Y0.81%
Sales Q2Q%-14.75%

3.2 Future

Based on estimates for the next years, TSE will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.91% on average per year.
The Revenue is expected to grow by 5.12% on average over the next years.
EPS Next Y11.83%
EPS Next 2Y12.7%
EPS Next 3Y10.91%
EPS Next 5YN/A
Revenue Next Year-4.46%
Revenue Next 2Y0.08%
Revenue Next 3Y5.12%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TSE Yearly Revenue VS EstimatesTSE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
TSE Yearly EPS VS EstimatesTSE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 -5 10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

TSE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year TSE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TSE Price Earnings VS Forward Price EarningsTSE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TSE is valued a bit more expensive than the industry average as 61.90% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.5
TSE Per share dataTSE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.7%
EPS Next 3Y10.91%

More info and screens

2

5. Dividend

5.1 Amount

TSE has a Yearly Dividend Yield of 1.81%. Purely for dividend investing, there may be better candidates out there.
TSE's Dividend Yield is comparable with the industry average which is at 3.54.
TSE's Dividend Yield is slightly below the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 1.81%

5.2 History

The dividend of TSE decreases each year by -50.57%.
TSE has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-50.57%
Div Incr Years0
Div Non Decr Years0
TSE Yearly Dividends per shareTSE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

The earnings of TSE are negative and hence is the payout ratio. TSE will probably not be able to sustain this dividend level.
DP-0.44%
EPS Next 2Y12.7%
EPS Next 3Y10.91%
TSE Yearly Income VS Free CF VS DividendTSE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

More info and screens

TRINSEO PLC

NYSE:TSE (8/28/2025, 3:00:44 PM)

2.38

-0.07 (-2.86%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners71.19%
Inst Owner Change9.59%
Ins Owners6.2%
Ins Owner Change32.96%
Market Cap85.56M
Analysts49.09
Price Target3.52 (47.9%)
Short Float %6.47%
Short Ratio5.02
Dividend
Industry RankSector Rank
Dividend Yield 1.81%
Yearly Dividend0.05
Dividend Growth(5Y)-50.57%
DP-0.44%
Div Incr Years0
Div Non Decr Years0
Ex-Date07-10 2025-07-10 (0.01)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-20.06%
Min EPS beat(2)-41.11%
Max EPS beat(2)0.99%
EPS beat(4)1
Avg EPS beat(4)-16.28%
Min EPS beat(4)-41.11%
Max EPS beat(4)0.99%
EPS beat(8)2
Avg EPS beat(8)-25.06%
EPS beat(12)2
Avg EPS beat(12)-56.95%
EPS beat(16)3
Avg EPS beat(16)-44.76%
Revenue beat(2)0
Avg Revenue beat(2)-11.19%
Min Revenue beat(2)-14.85%
Max Revenue beat(2)-7.53%
Revenue beat(4)0
Avg Revenue beat(4)-6.54%
Min Revenue beat(4)-14.85%
Max Revenue beat(4)-0.57%
Revenue beat(8)1
Avg Revenue beat(8)-4.85%
Revenue beat(12)1
Avg Revenue beat(12)-6.37%
Revenue beat(16)2
Avg Revenue beat(16)-4.97%
PT rev (1m)-16.36%
PT rev (3m)-37.27%
EPS NQ rev (1m)-8.72%
EPS NQ rev (3m)-73.23%
EPS NY rev (1m)-12.97%
EPS NY rev (3m)-21.34%
Revenue NQ rev (1m)-5.53%
Revenue NQ rev (3m)-14.93%
Revenue NY rev (1m)-4.11%
Revenue NY rev (3m)-7.62%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 15.5
EPS(TTM)-7.78
EYN/A
EPS(NY)-5.61
Fwd EYN/A
FCF(TTM)-1.71
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS90.63
BVpS-20.87
TBVpS-38.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.81%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.27%
FCFM N/A
ROA(3y)-15.93%
ROA(5y)-7.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-72.52%
OM growth 5Y-32.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.47%
GM growth 5Y-3.22%
F-Score3
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 14.73
Cap/Depr 24.21%
Cap/Sales 1.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 0.89
Altman-Z 0.8
F-Score3
WACC7.04%
ROIC/WACCN/A
Cap/Depr(3y)41.39%
Cap/Depr(5y)51.15%
Cap/Sales(3y)2.23%
Cap/Sales(5y)2.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-45.21%
EPS Next Y11.83%
EPS Next 2Y12.7%
EPS Next 3Y10.91%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.97%
Revenue growth 3Y-10.05%
Revenue growth 5Y0.81%
Sales Q2Q%-14.75%
Revenue Next Year-4.46%
Revenue Next 2Y0.08%
Revenue Next 3Y5.12%
Revenue Next 5YN/A
EBIT growth 1Y36.61%
EBIT growth 3Y-75.28%
EBIT growth 5Y-32.27%
EBIT Next Year665.13%
EBIT Next 3Y121.04%
EBIT Next 5YN/A
FCF growth 1Y-158.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-104.07%
OCF growth 3YN/A
OCF growth 5YN/A